Latest news
CLC bio expands bioinformatics consulting organization in North America
The organization, based in Washington, D.C., will function as an integrated part of CLC bio’s global consulting team. Dr. Saul A. Kravitz, formerly Director of Bioinformatics Software at the J. Craig Venter Institute has joined CLC bio and will lead the North American consulting organization.


Prior to joining CLC bio, Dr. Saul A. Kravitz served in leadership positions at the J. Craig Venter Institute. He joined JCVI during its startup in 2002, and his team developed the award-winning LIMS supporting JCVI’s DNA sequence facility. In addition, he was responsible for development and operation of JCVI’s high-throughput analysis pipelines for assembly, polymorphism detection, and annotation. Previously at Celera Genomics, he built and managed the team that developed novel algorithms and software infrastructure supporting high-throughput protein identification and quantitation from mass spectrometry data, and made key contributions to the development of Celera's Whole Genome Shotgun Assembler.
Dr. Kravitz earned MSc and PhD degrees in Electrical and Computer Engineering at Carnegie Mellon University, and a BA in Physics from The Johns Hopkins University.


















